Pharmacokinetics of HLD200 in Children and Adolescents With ADHD

NCT01907360 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

29

Enrollment

OTHER

Sponsor class

Conditions

Attention-Deficit Hyperactivity Disorder

Interventions

DRUG: HLD200 (methylphenidate hydrochloride)

Sponsor

Ironshore Pharmaceuticals and Development, Inc